Pharmadax focuses on developing and manufacturing specialty generic medicines. It is building a specialty pharmaceutical company with enhanced focus on specialty modified release products.
Company (Alive / Active)
5F-1 No. 236 Liancheng Rd.
New Taipei City, 23553
|Title||Application Date||Patent Date||Status
(Patent / Application)
|Sustained release oral dosage form containing dalfampridine||Sep 05, 2016||Jan 08, 2019||Patent|
|Method of preparing drug agglomerate||Apr 28, 2017||Dec 05, 2017||Patent|
|Method of preparing drug agglomerate||Oct 13, 2015||Jun 06, 2017||Patent|